NR3C2 and dilated cardiomyopathy: Indeed, Kasama et al. (2003, 2011, 2013) revealed that MR antagonist spironolactone not only enhances left ventricular remodeling, but also increases cardiac sympathetic nerve activity in patients with dilated cardiomyopathy.